Cetuximab for Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: A NICE Single Technology Appraisal

Author： Bagust Adrian  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.28, Iss.6, 2010-06, pp. : 439-448

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck

By  

Cancer, Vol. 120, Iss. 24, 2014-12 ,pp. : 3940-3951

Blackwell Publishing

Access to resources Recommend Favorite

Cetuximab: A Review of its Use in Squamous Cell Carcinoma of the Head and Neck and Metastatic Colorectal Cancer

By Blick Stephanie K.A.   Scott Lesley J.  

Drugs, Vol. 67, Iss. 17, 2007-01 ,pp. : 2585-2607

Adis International

Access to resources Recommend Favorite

Cetuximab: A Review of its Use in Squamous Cell Carcinoma of the Head and Neck

By Frampton James E.  

Drugs, Vol. 70, Iss. 15, 2010-10 ,pp. : 1987-2010

Adis International

Access to resources Recommend Favorite

Topoisomerases in the treatment of metastatic or recurrent squamous carcinoma of the head and neck

By Murphy Barbara A  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 1, 2005-01 ,pp. : 85-92

Informa Healthcare

Access to resources Recommend Favorite

Combination therapy with erlotinib and cisplatin is effective in patients with recurrent or metastatic squamous cell cancer of the head and neck

By  

Inpharma, Vol. 1, Iss. 1591, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite